Ambea (AMBEA.ST) Stock Analysis & AI Equity Report
Ambea (AMBEA.ST) overview
Ambea (AMBEA.ST) stock analysis and AI equity research. For the latest completed financial year, 2025, Ambea reported revenue of SEK 16,039m and operating profit of SEK 1,202m; the year-end share price was 141.30 SEK and market capitalisation was SEK 11,826m. Ambea is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Ambea's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2026-07-18. Data will be refreshed during report generation.
About Ambea
Ambea AB is a Nordic care provider focused on elderly care, disability services and psychosocial support. Through brands such as Vardaga, Nytida, Stendi, Altiden and Validia, it operates more than 1,000 care units across Sweden, Norway, Denmark and Finland. Its business is driven by staffed care homes, support services and related operational contracts.
Generate the Ambea report
Ambea is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Ambea and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.